Aurinia Pharmaceuticals, Inc. (AUPH)
16.58
-0.07
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Shareholders Equity (Quarterly) : 614.86M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 614.86M |
| March 31, 2026 | 567.63M |
| December 31, 2025 | 581.33M |
| September 30, 2025 | 365.77M |
| June 30, 2025 | 335.30M |
| March 31, 2025 | 350.19M |
| December 31, 2024 | 377.48M |
| September 30, 2024 | 388.00M |
| June 30, 2024 | 364.62M |
| March 31, 2024 | 359.48M |
| December 31, 2023 | 377.95M |
| September 30, 2023 | 391.88M |
| June 30, 2023 | 392.29M |
| March 31, 2023 | 390.41M |
| December 31, 2022 | 405.44M |
| September 30, 2022 | 423.42M |
| June 30, 2022 | 423.77M |
| March 31, 2022 | 448.12M |
| December 31, 2021 | 479.09M |
| September 30, 2021 | 298.17M |
| June 30, 2021 | 332.26M |
| March 31, 2021 | 370.23M |
| December 31, 2020 | 407.75M |
| September 30, 2020 | 398.84M |
| June 30, 2020 | 239.04M |
| Date | Value |
|---|---|
| March 31, 2020 | 263.41M |
| December 31, 2019 | 273.52M |
| September 30, 2019 | 123.74M |
| June 30, 2019 | 125.87M |
| March 31, 2019 | 139.34M |
| December 31, 2018 | 112.58M |
| September 30, 2018 | 125.34M |
| June 30, 2018 | 142.17M |
| March 31, 2018 | 152.45M |
| December 31, 2017 | 165.74M |
| September 30, 2017 | 167.64M |
| June 30, 2017 | 178.46M |
| March 31, 2017 | 172.66M |
| December 31, 2016 | 35.95M |
| September 30, 2016 | 20.10M |
| June 30, 2016 | 19.54M |
| March 31, 2016 | 16.02M |
| December 31, 2015 | 19.96M |
| September 30, 2015 | 23.54M |
| June 30, 2015 | 28.01M |
| March 31, 2015 | 27.56M |
| December 31, 2014 | 45.11M |
| September 30, 2014 | 49.32M |
| June 30, 2014 | 51.07M |
| March 31, 2014 | 54.62M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | 255.17M |
| Medicus Pharma Ltd. | -1.243M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.242B |
| Psyence Biomedical Ltd. | 11.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 792.26M |
| Total Liabilities (Quarterly) | 177.40M |
| Debt to Equity Ratio | 0.1043 |
| Current Ratio | 5.419 |
| Net Debt Paydown Yield | 0.12% |